Have a feature idea you'd love to see implemented?
Let us know!
MBOT Microbot Medical Inc
Price (delayed)
$0.9354
Market cap
$15.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.81
Enterprise value
$13.07M
Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary
Highlights
Microbot Medical's debt has plunged by 53% YoY and by 29% from the previous quarter
Microbot Medical's EPS has increased by 45% YoY and by 9% QoQ
MBOT's quick ratio is down by 36% YoY and by 10% from the previous quarter
The equity has decreased by 36% YoY
Key stats
What are the main financial stats of MBOT
Market
Valuations
Earnings
Shares outstanding
16.5M
Market cap
$15.44M
Enterprise value
$13.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.22
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$10.44M
EBITDA
-$10.34M
Free cash flow
-$7.89M
Per share
Balance sheet
Liquidity
EPS
-$0.81
Free cash flow per share
-$0.53
Book value per share
$0.42
Revenue per share
$0
TBVPS
$0.5
Total assets
$7.43M
Total liabilities
$1.38M
Debt
$148,000
Equity
$6.06M
Working capital
$5.8M
Debt to equity
0.02
Current ratio
5.32
Quick ratio
4.85
Net debt/EBITDA
0.23
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-130.4%
Return on equity
-173.3%
Return on invested capital
-239.6%
Return on capital employed
-171.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBOT stock price
How has the Microbot Medical stock price performed over time
Intraday
-1.57%
1 week
-7.39%
1 month
4.63%
1 year
-17.22%
YTD
-42.96%
QTD
4.63%
Financial performance
How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.51M
Net income
-$10.44M
Gross margin
N/A
Net margin
N/A
MBOT's operating income is up by 19% year-on-year but it is down by 2% since the previous quarter
MBOT's net income is up by 10% year-on-year
Growth
What is Microbot Medical's growth rate over time
Valuation
What is Microbot Medical stock price valuation
P/E
N/A
P/B
2.22
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 45% YoY and by 9% QoQ
The equity has decreased by 36% YoY
The stock's price to book (P/B) is 21% less than its 5-year quarterly average of 2.9 and 21% less than its last 4 quarters average of 2.9
Efficiency
How efficient is Microbot Medical business performance
The company's return on invested capital rose by 25% YoY but it fell by 4% QoQ
The ROE has contracted by 16% from the previous quarter
MBOT's return on assets is down by 13% since the previous quarter but it is up by 4.4% year-on-year
Dividends
What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBOT.
Financial health
How did Microbot Medical financials performed over time
MBOT's quick ratio is down by 36% YoY and by 10% from the previous quarter
The current ratio is down by 32% YoY and by 10% from the previous quarter
Microbot Medical's debt is 98% less than its equity
Microbot Medical's debt has plunged by 53% YoY and by 29% from the previous quarter
The equity has decreased by 36% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.